Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine

Bin Ju; Bing Zhou; Shuo Song; Qing Fan; Xiangyang Ge; Haiyan Wang; Lin Cheng; Huimin Guo; Dan Shu; Lei Liu; Zheng Zhang

doi:10.1002/ctm2.732

Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine

Clin Transl Med. 2022 Feb;12(2):e732. doi: 10.1002/ctm2.732.

Authors

Bin Ju^{1

2

3}, Bing Zhou^{1

2}, Shuo Song^{1

2}, Qing Fan^{1

2}, Xiangyang Ge^{1

2}, Haiyan Wang^{1

2}, Lin Cheng^{1

2}, Huimin Guo^{1

2}, Dan Shu^{1

2}, Lei Liu^{2

4}, Zheng Zhang^{1

2

3

5}

Affiliations

¹ Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
² The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
³ Guangdong Key Laboratory for Anti-infection Drug Quality Evaluation, Shenzhen, China.
⁴ Department for Infectious Diseases, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, China.
⁵ Shenzhen Research Center for Communicable Disease Diagnosis and Treatment of Chinese Academy of Medical Science, Shenzhen, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral / analysis
Antibodies, Viral / immunology*
COVID-19 / immunology
COVID-19 / prevention & control
COVID-19 Drug Treatment*
COVID-19 Vaccines / analysis*
COVID-19 Vaccines / therapeutic use
Humans
Vaccines, Inactivated / analysis
Vaccines, Inactivated / therapeutic use

Substances

Antibodies, Viral
COVID-19 Vaccines
Vaccines, Inactivated

Publication types

MeSH terms

Substances

Grants and funding